tiprankstipranks
Trending News
More News >
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
India Market

Akums Drugs and Pharmaceuticals Limited (AKUMS) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

AKUMS Financial Forecast

AKUMS Earnings Forecast

The previous quarter’s earnings for AKUMS were ₹2.60.
The previous quarter’s earnings for AKUMS were ₹2.60.

AKUMS Sales Forecast

The previous quarter’s earnings for AKUMS were ₹10.18B.
The previous quarter’s earnings for AKUMS were ₹10.18B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AKUMS
ICICI Securities
ICICI Securities
₹710₹655
Buy
54.97%
Upside
Reiterated
08/12/25
ICICI Securities Sticks to Their Buy Rating for Akums Drugs and Pharmaceuticals Limited (AKUMS)
Citi
₹700
Buy
65.62%
Upside
Initiated
03/12/25
Citi Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at BuyCiti analyst Vivek Agrawal initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy rating and a price target of INR700.00.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AKUMS
ICICI Securities
ICICI Securities
₹710₹655
Buy
54.97%
Upside
Reiterated
08/12/25
ICICI Securities Sticks to Their Buy Rating for Akums Drugs and Pharmaceuticals Limited (AKUMS)
Citi
₹700
Buy
65.62%
Upside
Initiated
03/12/25
Citi Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at BuyCiti analyst Vivek Agrawal initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy rating and a price target of INR700.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Akums Drugs and Pharmaceuticals Limited

1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-12.35%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -12.35% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-12.75%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -12.75% per trade.
1 Year
Abdulkader PuranwalaICICI Securities
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.70%
reiterated a buy rating 4 months ago
Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.70% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-22.80%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -22.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AKUMS Analyst Recommendation Trends

Rating
Jan 25
Mar 25
Aug 25
Strong Buy
0
0
0
Buy
1
2
3
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
In the current month, AKUMS has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AKUMS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

AKUMS Stock Forecast FAQ

What is IN:AKUMS’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:AKUMS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:AKUMS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Akums Drugs and Pharmaceuticals Limited a Buy, Sell or Hold?
      Akums Drugs and Pharmaceuticals Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Akums Drugs and Pharmaceuticals Limited’s share price target?
        Currently, no data Available
        What do analysts say about Akums Drugs and Pharmaceuticals Limited?
        Akums Drugs and Pharmaceuticals Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Akums Drugs and Pharmaceuticals Limited?
          To buy shares of IN:AKUMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.